Author: Biotech Express

Kiran Mazumdar Shaw have been chosen as Foreign Members to the National Academy of Engineering (NAE). NAE is a US-based private, independent, and non-profit institution, which is a part of the National Academies of Sciences, Engineering, and Medicine, and provides engineering leadership in service to the nation. Reacting to the announcement, Dr Mazumdar-Shaw noted that she is humbled to receive this recognition. She tweeted ‘‘Just learnt of my induction to the National Academy of Engineering NAE – a huge honour – I am humbled to be elected to this prestigious body.’’ This year, the National Academy of Engineering has elected…

Tecan, Maennedorf, Switzerland, has announced the launch of its NGS DreamPrep, a fully automated approach to next-generation sequencing (NGS) library preparation for research use. The new approach offers quality-controlled, sequencing-ready NGS libraries within hours, with minimal manual interaction and no sample loss. NGS DreamPrep combines the Tecan Fluent liquid handler and Infinite plate reader together with Celero DNA-Seq and Universal Plus mRNA-Seq library preparation kits to improve speed, flexibility, accuracy, and precision. Quantification, normalization, and pooling of samples can all be achieved in significantly shorter timelines compared to other methods that use qPCR or capillary electrophoresis. Importantly, this is the…

Scientist Dr. Ashok Pandey, is in the list of World’s most influential scientist in the world along with nine other Indian scientists. The report is prepared by Clarivate Analytics. Dr. Pandey is the only scientist from CSIR and working in CSIR-IITR Lucknow. I have contacted Dr. Pandey to understand about the various aspects of reports. First of all congratulations to you for this great recognition. Definitely you deserve it, as I have seen you CV and it is having huge lists of your work either in form of research article, books or other related activities. Q- Highly Cited Researchers (HCRs),…

In the upcoming event BioAsia 2019 from 25-27 February 2019, a lot of fruitful discussion are expected to happen regarding business of Life Science, Biotech and Pharma companies in India. In this India’s biggest and finest Biotech industry meet, gathers industry’s leadrs under one roof and discusses ltest ongoings. The event is gaining much wider attention from last few years. In year 2017, intersting ideas were shared by Dr Vas Narsimha , Dr Paul stoffels, Dr Saumya Swaminthan, Prof. Michael Hall, Lasker Awardee 2017, Dr. Udit Batra, Member of the Executive Board, CEO Life Science, Merck , Mr. Satish Reddy,…

Introduction Progress is not about how we grow, it is about how we make a difference in lives of others! This is the guiding principle at Yashraj Biotechnology Limited (YBL), a pioneering biotechnology company located in Navi Mumbai, India. The founder members of the company Mr. Arvind Bhanushali, Mr. Bharat Dagha and Dr. Paresh Bhanushali started the company in 1999 and this year the company is celebrating its 20 years of existence. The company was established with a vision to be the best in the diagnostic field and make diagnostics affordable and easily available to the common man. Today, YBL…

Introduction Founded by Dr. K.I. Varaprasad Reddy in 1993, Shantha Biotechnics was one of the first Indian biotech to create a recombinant product, obtaining World Health Organization (WHO) prequalification for its Hepatitis B vaccine in 2002. Then, the firm grown to 750 employees and brought 11 novel products to market. In 2009, Shantha sold over 120 million doses of Hepatitis B vaccine to dozens of developing countries around the world and had revenues exceeding USD$90 million [1]. Later, in 2019, Shantha Biotechnics was acquired by the multinational giant Sanofi-Aventis (France) at a valuation of USD$784 million. The example given above…

Introduction Protein Biologics are class of Biopharmaceuticals that are composed of protein molecules. Biologics, in general, can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. Other Biologics include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy (including stem cells). Biosimilars are biologics that are highly similar to the reference biological product with no clinically meaningful differences in terms of safety profile, purity, and potency. Protein Biologics and Biosimilars include Modified human proteins, Monoclonal antibodies, Vaccines, Growth factors and cytokines, Hormones, and other protein Blood products.…

Introduction In 2005, eminent Indian scientist and late President A P J Abdul Kalam noted that India has the “potential to tap research opportunities in proteomics and biochips to help understand the biological processes and treat diseases. This is possible even though the country has missed the opportunity to partner in the human genome project India has no dearth of protein Scientists and some like Har Gobind Khorana and G N Ramachandran have received global recognition for their outstanding discovery of Ribosome structure which has revolutionized the way drug makers think. The proteomics in India was mainly started with cancer…

Abstract It was the first time in 1789 when Antoine Fourcroy distinguished several types of proteins (then called “albumins” or “Eiweisskörper”) such as albumin, fibrin, gelatin, and gluten. Today in 2019 we have evolved to Proteomics when we can study total proteins of a cell or an individual. The transistion occur due to knowledge and efforts of great many scientists which is further helping us to combat major issues like medical, food, environment and many others.

Do investigations into research misconduct allegations need better standards? The Association for the Promotion of Research Integrity (APRIN) in Japan, a group of volunteers who “commit themselves to the promotion of research of high integrity” and provide “e-learning material for research ethics education,” thinks so. Today, we present a guest post by Iekuni Ichikawa, who chaired an APRIN committee that recently came up with a new checklist for such investigations, about the effort. The procedures currently employed by various institutions in Japan are highly variable; hence there is a risk that complainants or respondents might be treated unfairly and that…